Jonathan Guarino
Director of Finance/CFO bij SOLIGENIX, INC.
Vermogen: 440 $ op 31-03-2024
Profiel
Jonathan L.
Guarino is currently the Chief Financial Officer, Secretary & Senior VP at Soligenix, Inc. Prior to this, he worked as the Controller at Hepion Pharmaceuticals, Inc. from 2016 to 2019.
He also served as the Senior Manager-Technical Accounting at Labcorp Drug Development, Inc. from 2014 to 2015 and as the Controller at Suite-K Value Added Services LLC from 2015 to 2016.
Mr. Guarino completed his undergraduate degree at Montclair State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SOLIGENIX, INC.
0.01% | 08-03-2024 | 734 ( 0.01% ) | 440 $ | 31-03-2024 |
Actieve functies van Jonathan Guarino
| Bedrijven | Functie | Begin |
|---|---|---|
| SOLIGENIX, INC. | Director of Finance/CFO | 11-09-2019 |
Eerdere bekende functies van Jonathan Guarino
| Bedrijven | Functie | Einde |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-07-2019 |
| Suite-K Value Added Services LLC | Comptroller/Controller/Auditor | 01-09-2016 |
| COVANCE INC. | Comptroller/Controller/Auditor | 01-05-2015 |
Opleiding van Jonathan Guarino
| Montclair State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
| Suite-K Value Added Services LLC |
